NEW YORK ( TheStreet) -- NuVasive (Nasdaq: NUVA) hit a new 52-week low Wednesday as it is currently trading at $19.74, below its previous 52-week low of $19.99 with 706,156 shares traded as of 9:36 a.m. ET. Average volume has been 975,000 shares over the past 30 days.

NuVasive has a market cap of $859.3 million and is part of the health care sector and health services industry. Shares are down 16% year to date as of the close of trading on Tuesday.

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. Its products are used in applications for spine fusion surgery. The company has a P/E ratio of 11.6, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
  • Practice your NUVA trading strategies and win cash in our stock game.

TheStreet Ratings rates NuVasive as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and generally poor debt management. You can view the full NuVasive Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

Masimo's Stock Is a Great Buy Right Now

NXPI, AAPL, C: Jim Cramer's Views

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook